Laura has built an impressive career as Program Director in some of the largest multinational CROs, delivering high-value and high-complexity global trials, from Ph 1 through Ph 3.
An accomplished leader, she has led large, multicultural teams all while ensuring high quality in delivery. Laura is extremely experienced when it comes to working with CDMOs and third-party vendors across all aspects of clinical trials which makes her an invaluable asset across the business.
Clinical trials have been significantly affected by COVID-19. On one hand, there is a...Read article
In our blog ‘What makes a sensational CRO website?’ we discussed how the top...Read article
The contract research organisation (CRO) market is an alluring place to be right now....Read article